Document Detail


Fas receptor is required for estrogen deficiency-induced bone loss in mice.
MedLine Citation:
PMID:  20084056     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Bone mass is determined by bone cell differentiation, activity, and death, which mainly occur through apoptosis. Apoptosis can be triggered by death receptor Fas (CD95), expressed on osteoblasts and osteoclasts and may be regulated by estrogen. We have previously shown that signaling through Fas inhibits osteoblast differentiation. In this study we analyzed Fas as a possible mediator of bone loss induced by estrogen withdrawal. At 4 weeks after ovariectomy (OVX), Fas gene expression was greater in osteoblasts and lower in osteoclasts in ovariectomized C57BL/6J (wild type (wt)) mice compared with sham-operated animals. OVX was unable to induce bone loss in mice with a gene knockout for Fas (Fas -/- mice). The number of osteoclasts increased in wt mice after OVX, whereas it remained unchanged in Fas -/- mice. OVX induced greater stimulation of osteoblastogenesis in Fas -/- than in wt mice, with higher expression of osteoblast-specific genes. Direct effects on bone cell differentiation and apoptosis in vivo were confirmed in vitro, in which addition of estradiol decreased Fas expression and partially abrogated the apoptotic and differentiation-inhibitory effect of Fas in osteoblast lineage cells, while having no effect on Fas-induced apoptosis in osteoclast lineage cells. In conclusion, the Fas receptor has an important role in the pathogenesis of postmenopausal osteoporosis by mediating apoptosis and inhibiting differentiation of osteoblast lineage cells. Modulation of Fas effects on bone cells may be used as a therapeutic target in the treatment of osteoresorptive disorders.
Authors:
Natasa Kovacic; Danka Grcevic; Vedran Katavic; Ivan Kresimir Lukic; Vladimir Grubisic; Karlo Mihovilovic; Hrvoje Cvija; Peter Ian Croucher; Ana Marusic
Related Documents :
15601766 - Activation of liver x receptors and retinoid x receptors prevents bacterial-induced mac...
12522536 - Shedding of fas ectodomain that affects apoptosis of hepatocytes occurring in regenerat...
10208976 - Death receptor fas/apo-1/cd95 expressed by human placental cytotrophoblasts does not me...
9759926 - Apoptosis by retrovirus- and adenovirus-mediated gene transfer of fas ligand to glioma ...
15307936 - T-lymphocyte cytokine production patterns in nonimmune severe hypothyroid state and aft...
12941656 - Ribavirin or cpg dna sequence-modulated dendritic cells decrease the ige level and airw...
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't     Date:  2010-01-18
Journal Detail:
Title:  Laboratory investigation; a journal of technical methods and pathology     Volume:  90     ISSN:  1530-0307     ISO Abbreviation:  Lab. Invest.     Publication Date:  2010 Mar 
Date Detail:
Created Date:  2010-02-25     Completed Date:  2010-03-23     Revised Date:  2010-09-02    
Medline Journal Info:
Nlm Unique ID:  0376617     Medline TA:  Lab Invest     Country:  United States    
Other Details:
Languages:  eng     Pagination:  402-13     Citation Subset:  IM    
Affiliation:
Department of Anatomy, University of Zagreb, School of Medicine, Zagreb, Croatia. natasa@mef.hr
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Animals
Antigens, CD95 / metabolism*
Apoptosis
Cell Differentiation*
Cell Lineage
Cells, Cultured
Estrogens / deficiency*
Fas Ligand Protein / metabolism
Female
Mice
Mice, Inbred C57BL
Mice, Knockout
Osteoblasts / cytology*,  physiology
Osteoclasts / cytology*,  physiology
Osteoporosis / metabolism*
Ovariectomy
Signal Transduction
Grant Support
ID/Acronym/Agency:
073828//Wellcome Trust; CRIGS 073828/Z/03/Z//Wellcome Trust
Chemical
Reg. No./Substance:
0/Antigens, CD95; 0/Estrogens; 0/Fas Ligand Protein; 0/Fas protein, mouse

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Pretreatment with insulin-like growth factor I protects skeletal muscle cells against oxidative dama...
Next Document:  TIMP-2 modulates VEGFR-2 phosphorylation and enhances phosphodiesterase activity in endothelial cell...